{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:09:19Z","timestamp":1788174559177,"version":"build-2803163510"},"reference-count":35,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2026,4,16]]},"DOI":"10.1080\/10428194.2026.2628361","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:04:29Z","timestamp":1772712269000},"page":"1088-1099","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Ruxolitinib treatment for myelofibrosis with anemia: a retrospective assessment of real-world patient characteristics, treatment patterns, and survival"],"prefix":"10.1080","volume":"67","author":[{"given":"Andrew T.","family":"Kuykendall","sequence":"first","affiliation":[{"name":"Moffitt Cancer Center","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Palandri","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia \u201cSer\u00e0gnoli,\u201d","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Fillbrunn","sequence":"additional","affiliation":[{"name":"Analysis Group","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Liu","sequence":"additional","affiliation":[{"name":"GSK plc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"GSK plc","place":["Collegeville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Zhang","sequence":"additional","affiliation":[{"name":"Analysis Group","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Simpson","sequence":"additional","affiliation":[{"name":"Analysis Group","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sajeev","sequence":"additional","affiliation":[{"name":"Analysis Group","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[{"name":"Analysis Group","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwaipayan","family":"Patnaik","sequence":"additional","affiliation":[{"name":"GSK plc","place":["Baar, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron T.","family":"Gerds","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Taussig Cancer Institute","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.001"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000001"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.02.016"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0028-x"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.031831"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2023.41.16_suppl.7066"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103862"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05126-4"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-79"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0642-0"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179402"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34722"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S53348"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1845334"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.119545"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006889"},{"key":"e_1_3_4_18_1","volume-title":"Poster presented at: 2024 EHA Congress","author":"Al-Ali HK","year":"2024","unstructured":"Al-Ali HK, Guglielmelli P, Hamer-Maansson JE, et\u00a0al. The impact of new or worsening anemia on clinical outcomes in 2233 patients with myelofibrosis treated with ruxolitinib: results from the expanded-access JUMP study. Poster presented at: 2024 EHA Congress; June 13-16, 2024; Madrid, Spain. Poster P1044."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151449"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179417"},{"key":"e_1_3_4_21_1","unstructured":"Birnbaum B Nussbaum B Seidl-Rathkopf K et\u00a0al. Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the EHR for oncology research. arXiv 2020;2001.09765 (preprint)."},{"key":"e_1_3_4_22_1","article-title":"Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR","author":"Ma X","year":"2023","unstructured":"Ma X, Long L, Moon S, et\u00a0al. Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR. medRxiv. 2023;2020.2003.2016.20037143 (preprint).","journal-title":"medRxiv"},{"key":"e_1_3_4_23_1","volume-title":"Prescribing information","author":"Jakafi (ruxolitinib)","year":"2021","unstructured":"Jakafi (ruxolitinib). Prescribing information. Wilmington, DE: Incyte Corporation; 2021. Accessed April 4, 2025. https:\/\/www.jakafi.com\/jakafi-prescribing-information."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2024.12.013"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)00742-0"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06279-0"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181137"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2446"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01637-7"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35156"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19812"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-02928-4"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2328800"},{"key":"e_1_3_4_34_1","unstructured":"Ojjaara (momelotinib). Prescribing information. Durham NC: GSK; 2023. Accessed April 4 2025. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Ojjaara\/pdf\/OJJAARA-PI-PIL.PDF."},{"key":"e_1_3_4_35_1","unstructured":"Vonjo (pacritinib). Prescribing information. Waltham MA: Sobi Inc. 2024. Accessed April 4 2025. https:\/\/www.vonjo.com\/sites\/default\/files\/2024-09\/prescribing-information.pdf."},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010151"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2628361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:52:57Z","timestamp":1776790377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2026.2628361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,16]]}},"alternative-id":["10.1080\/10428194.2026.2628361"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2026.2628361","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}